That is great news and another blue sky opportunity for Atomo in the future.
I spoke with John Kelly at the Microcaps conference last month and he mentioned they will be commissioned by Nexsen to develop the technology.
They must like what they see so far to also commit to manufacturing for pivotal clinical trials.
Nexsen have received $5.5M in grant funding so far.
- Forums
- ASX - By Stock
- AT1
- AT1 FY21 - General Discussion + FA
AT1 FY21 - General Discussion + FA, page-2433
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.3¢ |
Change
0.001(4.55%) |
Mkt cap ! $14.70M |
Open | High | Low | Value | Volume |
2.0¢ | 2.3¢ | 2.0¢ | $1.21K | 55.02K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 314348 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 152314 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 314348 | 0.020 |
5 | 604260 | 0.019 |
9 | 1162558 | 0.018 |
3 | 410000 | 0.017 |
1 | 62561 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 99683 | 1 |
0.024 | 631111 | 3 |
0.025 | 459000 | 2 |
0.026 | 1590045 | 4 |
0.027 | 683000 | 3 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |